Graduate Diploma in Drug Evaluation and Pharmaceutical Sciences

Course 133-AB (2008)

Note: This is an archived Handbook entry from 2008.Search for this in the current handbookSearch for this in the current handbook

Year and Campus: 2008
Fees Information: Subject EFTSL, Level, Discipline & Census Date
Level: Graduate/Postgraduate

Contact

Course Administrator: Mrs Nicola Cash njcash@unimelb.edu.au
Course Overview: The Graduate Diploma in Drug Evaluation and Pharmaceutical Sciences expands the knowledge base of pharmacists, scientists and physicians in the pharmaceutical industry and in regulatory bodies with respect to basic pharmacology, toxicology, pharmaceutical sciences, quality control issues, clinical trial methodology and interpretation and therapeutics as they relate to drug evaluation.
Objectives: .
Subject Options: Students must satisfactorily complete the five core subjects to qualify for the Graduate Diploma in Drug Evaluation and Pharmaceutical Science.
Subject
Study Period Commencement:
Credit Points:
Entry Requirements: The course is available to graduate with degrees in medicine, pharmacy or science, or applicants with other approved qualifications.
Core Participation Requirements:

For the purposes of considering request for Reasonable Adjustments under the Disability Standards for Education (Cwth 2005), and Student Support and Engagement Policy, academic requirements for this subject are articulated in the Subject Overview, Learning Outcomes, Assessment and Generic Skills sections of this entry.

It is University policy to take all reasonable steps to minimise the impact of disability upon academic study, and reasonable adjustments will be made to enhance a student's participation in the University's programs. Students who feel their disability may impact on meeting the requirements of this subject are encouraged to discuss this matter with a Faculty Student Adviser and Student Equity and Disability Support: http://services.unimelb.edu.au/disability

Graduate Attributes: None
Notes: The course is presented as weekly interactive video conferencing sessions. This approach has allowed for the provision of live lectures by internationally renowned faculty from the US Food and Drug Administration (FDA), Harvard Medical School and the World Health Organisation (WHO). Facilities to permit participation will be contingent upon sufficient students enrolling for that site. Recorded videotapes will be available for those students unable to attend a video conferencing centre. The videos may also be borrowed by any student for revision purposes.

Download PDF version.